Is Godavari Drugs a good stock to invest in?

Godavari Drugs can be analyzed on the following key metrics - TTM P/E: 13.35 Sector P/E: 26.12 Dividend Yield: 0% D/E ratio: -

Godavari Drugs Share Price

Sector: Biotechnology & Drugs

Powered by

99.57 -12.25 (-10.96%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 96.05

Today’s High 105.00

52 Week Low 79.00

52 Week High 155.00

Key Metrics

Market Cap (In Cr) 74.98
Beta 0.95
Div. Yield (%) 0
P/B 1.92
TTM P/E 13.35
Sector P/E 26.12
Open Price 105
Prev Close 111.82

View All Metrics

Godavari Drugs Analysis

Price Analysis

1 Week

1.11%
3 Months

21.5%
6 Month

-19.38%
YTD

-8.94%
1 Year

9.36%

Risk Meter

50% Low risk
50% Moderate risk
50% Balanced Risk
50% High risk
50% Extreme risk

Godavari Drugs News

Premium

Godavari Drugs Q3 FY24 Results Live: Profit Rises by 82.47% YoY

1 min read . 16 Feb 2024

View More News

Godavari Drugs Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2024

Total Revenue
156.71

Selling/ General/ Admin Expenses Total
5.26

Depreciation/ Amortization
1.99

Other Operating Expenses Total
17.34

Total Operating Expense
145.49

Operating Income
11.22

Net Income Before Taxes
6.92

Net Income
5.55

Diluted Normalized EPS
7.47

Period
2023

Total Revenue
159.62

Selling/ General/ Admin Expenses Total
4.96

Depreciation/ Amortization
1.94

Other Operating Expenses Total
16.69

Total Operating Expense
151.42

Operating Income
8.21

Net Income Before Taxes
4.93

Net Income
3.79

Diluted Normalized EPS
4.8

Period
2022

Total Revenue
161.11

Selling/ General/ Admin Expenses Total
5.07

Depreciation/ Amortization
1.7

Other Operating Expenses Total
14.3

Total Operating Expense
151.51

Operating Income
9.59

Net Income Before Taxes
7.02

Net Income
5.25

Diluted Normalized EPS
6.97

Period
2021

Total Revenue
122.67

Selling/ General/ Admin Expenses Total
4.04

Depreciation/ Amortization
1.22

Other Operating Expenses Total
12.21

Total Operating Expense
114.07

Operating Income
8.6

Net Income Before Taxes
5.71

Net Income
4.13

Diluted Normalized EPS
5.48

Period
2020

Total Revenue
95.7

Selling/ General/ Admin Expenses Total
3.49

Depreciation/ Amortization
1.16

Other Operating Expenses Total
9.5

Total Operating Expense
90.83

Operating Income
4.87

Net Income Before Taxes
2.29

Net Income
2

Diluted Normalized EPS
2.66

Period
2019

Total Revenue
83.54

Selling/ General/ Admin Expenses Total
3.5

Depreciation/ Amortization
1.09

Other Operating Expenses Total
9.66

Total Operating Expense
79.15

Operating Income
4.39

Net Income Before Taxes
1.75

Net Income
1.21

Diluted Normalized EPS
1.6

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Godavari Drugs Technical

Moving Average SMA

5 Day100.84
10 Day98.52
20 Day95

50 Day94.36
100 Day97.18
300 Day109.45

Godavari Drugs Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Source Natural Foods & Herb Supl
178.9
2.35
1.33
269.75
80.2
113.01

Mercury Laboratories
817.6
-13.5
-1.62
1190
736
98.11

Godavari Drugs
99.57
-12.25
-10.96
155
79
74.98

Biofil Chemicals And Pharma
49.5
-1.46
-2.86
92
40.5
81.26

Achyut Healthcare
3.33
-0.06
-1.77
6.25
2.82
78.44

Godavari Drugs Shareholding

Shareholding Pattern

*Promoter pledging: 0.13%

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

29-May-25
Audited Results

12-Feb-25
Quarterly Results

14-Nov-24
Quarterly Results

14-Aug-24
Quarterly Results

30-May-24
Quarterly Results

14-Feb-24
Quarterly Results

13-Feb-24
Quarterly Results

14-Nov-23
Quarterly Results

11-Aug-23
Quarterly Results

29-May-23
Audited Results

Meeting Date
Announced on
Purpose

29-Aug-24
05-Aug-24
AGM

12-Aug-23
21-Jul-23
AGM

16-May-22
25-Apr-22
AGM

14-Aug-21
22-Jul-21
AGM

View All

Company Profile

ABOUT Godavari Drugs

Industry Biotechnology & Drugs
ISIN INE362C01012
BSE Code 530317

Godavari Drugs Limited is an India-based company, which is engaged in the business of manufacturing of active pharmaceutical ingredients (API) and its intermediates. The Company is engaged in the business of contract manufacturing, loan license manufacturing, manufacturing and supply of API, drug intermediaries and fine chemicals. It operates through manufacture and sale of API and its intermediates segment. Its manufacturing facilities are located at the Maharashtra Industrial Development Corporation estate at Nanded, Maharashtra, India. The Company's facility has multiple production blocks for API's, drug intermediates and fine chemicals.

MANAGEMENT

Mukund Kakani Managing Director, Executive Director
Mohit Jaju Executive Director

GODAVARI DRUGS SUMMARY

Godavari Drugs is trading 10.96% lower at Rs 99.57 as compared to its last closing price. Godavari Drugs has been trading in the price range of 105.00 & 96.05. Godavari Drugs has given -8.94% in this year & 1.11% in the last 5 days.

Godavari Drugs has TTM P/E ratio 13.35 as compared to the sector P/E of 26.12.

The company posted a net profit of 0.77 Crores in its last quarter.

Listed peers of Godavari Drugs include Source Natural Foods & Herb Supl (1.33%), Mercury Laboratories (-1.62%), Godavari Drugs (-10.96%) etc.

Godavari Drugs has a 52.63% promoter holding & 47.37% public holding.

FAQs about Godavari Drugs

Godavari Drugs is trading at 99.57 as on 30 May, 2025 3:41:06 PM. This is -10.96% lower as compared to its previous closing price of 111.82

The market capitalization of Godavari Drugs is 74.98 Cr as on 30 May, 2025 3:41:06 PM.

The 52 wk high for Godavari Drugs is 155.00 whereas the 52 wk low is 79.00

Godavari Drugs can be analyzed on the following key metrics -

TTM P/E: 13.35
Sector P/E: 26.12
Dividend Yield: 0%
D/E ratio: -

Godavari Drugs reported a net profit of 5.55 Cr in 2024.

Godavari Drugs Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Godavari Drugs Share Price

Price Range

Key Metrics

Godavari Drugs Analysis

Godavari Drugs News

Godavari Drugs Q3 FY24 Results Live: Profit Rises by 82.47% YoY

Godavari Drugs Financials

Forecast

Forecast

Forecast

Godavari Drugs Technical

Godavari Drugs Peers

Godavari Drugs Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Godavari Drugs

MANAGEMENT

GODAVARI DRUGS SUMMARY

FAQs about Godavari Drugs

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue